MediciNova
MNOV
50 hedge funds and large institutions have $93.2M invested in MediciNova in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
62% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 13
24% more capital invested
Capital invested by funds: $75.1M → $93.2M (+$18.1M)
6% more funds holding
Funds holding: 47 → 50 (+3)
0.97% more ownership
Funds ownership: 21.5% → 22.47% (+0.97%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.45M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.58M |
| 3 |
Millennium Management
New York
|
+$1.19M |
| 4 |
D.E. Shaw & Co
New York
|
+$1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$970K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.06M |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$387K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$232K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$124K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$122K |
MNOV Hedge Fund Activity: Q2 2019 in Review
50 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2019, worth a combined $93.2M — up 24% from $75.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MNOV positions and 2 closed out — a net gain of 5 holders — while 21 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $3.45M. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $1.06M sold.
- 50 institutional investors held MediciNova (MNOV) as of Q2 2019, up from 47 in Q1 2019.
- Funds reported $93.2M of MediciNova stock for Q2 2019, up 24% quarter-over-quarter.
- 7 funds opened new MediciNova positions in Q2 2019 and 2 closed out, a net change of +5 holders.
- The largest MediciNova buyer in Q2 2019 was BlackRock, an estimated $3.45M added.
- The largest MediciNova seller in Q2 2019 was Bridgeway Capital Management, an estimated $1.06M sold.
Based on aggregated 13F filings for Q2 2019.